(VIANEWS) – Shares of FibroGen (NASDAQ Composite: FGEN) dropped 9.43% to $10.18 at 04:39 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ Composite is rising 1.02% to $14,896.85, after five consecutive sessions in a row of losses. This seems, up to now, an all-around bullish trend trading session today.
FibroGen’s last close was $11.27, 80.3% under its 52-week high of $57.21.
Today’s last reported volume for FibroGen is 3268391 which is 105.3% above its average volume of 1591995.
FibroGen’s sales growth is 201.9% for the ongoing quarter and 13.3% for the next. The company’s growth estimates for the current quarter is a negative 134.3% and positive 39.1% for the next.
Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $10.18 at 04:39 EST, way under its 52-week high of $57.21 and above its 52-week low of $9.89.
FibroGen’s Moving Average
FibroGen’s worth is way under its 50-day moving average of $12.18 and way under its 200-day moving average of $20.96.
More news about FibroGen (FGEN).